Adjuvant Therapy With Pegylated Interferon-Alfa2b as an Alternative to Systemic Therapy for Ulcerated Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Adjuvant Therapy With Pegylated Interferon-Alfa2b vs Observation in Stage II B/C Patients With Ulcerated Primary: Results of the European Organisation for Research and Treatment of Cancer 18081 Randomised Trial
Eur. J. Cancer 2020 Jul 01;133(xx)94-103, AMM Eggermont, P Rutkowski, C Dutriaux, et alFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.